{"version":"1.0","type":"link","title":"Application value and safety of trilaciclib in first-line chemotherapy combined with immunotherapy for extensive-stage small cell lung cancer: A real-world study.","author_name":"Cui Y 외","author_url":"https://prs-insight.online/author/Cui%20Y","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/101133","thumbnail_width":1200,"thumbnail_height":630}